Endothelin-1biomarker Features In Patients With Ankylosing Spondylitis After COVID-19

Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/2985

Full metadata record

DC Field	Value	Language
dc.contributor.author	РахимоваМ. , Ахмедов Х.С. , Тагаева М.Х. , Садыкова С.И., Разакова Ф., Халметова Ф.	-
dc.date.accessioned	2022-10-11T07:54:18Z	-
dc.date.available	2022-10-11T07:54:18Z	-
dc.date.issued	2022	-
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/2985	-
dc.description.abstract	Currently, there is no doubt about the importance of the role of impaired endothelial functional state in the development of vascular pathology in a number of diseases, including rheumatic. With the advent and large-scale spread of a new coronavirus infection (COVID-19), a high rate of patient’s hospitalizations with ankylosing spondyloarthritis (AS) and the development of extrapulmonary complications, such as myocardial injuries, kidney damage and vascular thromboembolism, were noted. The development of this phenomenon confirms the connection with pronounced endothelial dysfunction and its damage. This article presents the results of evaluation of endothelial dysfunction in AS patients undergoing COVID-19.	en_US
dc.language.iso	en	en_US
dc.publisher	Америка	en_US
dc.subject	ankylosing spondylitis, COVID-19, endothelial dysfunction	en_US
dc.title	Endothelin-1biomarker Features In Patients With Ankylosing Spondylitis After COVID-19	en_US
dc.type	Article	en_US
Appears in Collections:	Thesis, Articles

Files in This Item:

File	Description	Size	Format
2. скопус мавжуда холматовна скопус.pdf	Endothelin-1biomarker Features In Patients With Ankylosing Spondylitis After COVID-19	377.44 kB	Adobe PDF	View/Open

DSpace JSPUI